Posted on April 13, 20264/13/26
Beyond the Pilot: Scaling the Steep Climb of AI in Drug Safety
Posted on April 1, 20264/1/26
The Integrated Advantage: What Medical Affairs Needs Right Now
Posted on December 12, 202512/12/25
Consolidating Data Strategy For Global Success
Posted on September 10, 20259/10/25
2026 CMS Proposed Rule: BFSF Changes and Potential Risks for Pharma Manufacturers
Posted on September 10, 20259/10/25
Navigating OBBBA: Why a Strong GP Team is Essential for Pharma Compliance
Posted on July 21, 20257/21/25
Empowering Scientific Dialogue: Key Takeaways from the FDA’s SIUU Guidance
Posted on May 29, 20255/29/25
Navigating the Final FDA SIUU Guidance: Strategic Considerations for Scientific Exchange at ASCO and Other Congresses
Posted on June 28, 20246/28/24
European Parliament’s Revision of the General Pharmaceutical Legislation
Posted on June 3, 20246/3/24
Updated Guidance May Ease MDR Transition for SaMD Manufacturers
Posted on March 27, 20243/27/24